Life Science Tennessee: Statewide Beer & Biotech May 2020

On May 28, join Life Science Tennessee members from across the state for a virtual happy hour to stay connected and learn about the latest research and innovations. During this session, we will dig deeper into COVID-19 testing, treatment and prevention with leading experts on vaccine development and rapid, point-of-contact testing.

Featured speakers include (full bios below):

  • Dr. Rob Carnahan, Associate Director of the Vanderbilt Vaccine Center
  • Dr. Jonathan Peat, Business Development Manager of QuantuMDx
  • Dr. Andrea J. Pruijssers, Research Assistant Professor of Pediatrics at the Vanderbilt Institute for Infection, Immunology and Inflammation

Note: We will share a Zoom link with all registrants prior to the happy hour. Register here!

Learn more about the speakers

Dr. Rob Carnahan is the Associate Director of the Vanderbilt Vaccine Center. After several years working for Eli Lilly in the US and in Strasbourg, France, he returned to academics as a visiting researcher at the Institut Pasteur in Paris, France. He subsequently returned to the US to complete his Ph.D. in Cell Biology at Vanderbilt University. In 2006, he was appointed as Director of the Vanderbilt Antibody and Protein Resource (VAPR). During his time leading this institutional shared resource lab, he has guided a technology expansion from being a lab one focused exclusively on generating monoclonal antibodies, to one that now has expertise in wide array of molecular approaches, including antibody and recombinant protein engineering, diagnostic and assay development, and biologics cell line development. In 2010 he co-founded the Antibody-Technologies Research Group. This international group, part of a larger scientific organization (Association of Biomolecular Resource Facilities), collaborates to develop technical standards, advances in methodologies, and training opportunities for antibody lab directors and personnel.

Dr. Jonathan Peat is the Business Development Manager of QuantuMDx, with years of experience in molecular biology and commercialization. He began his career in Glasgow whilst studying for his Ph.D. in Immuno-Genetics. After a number of years carrying out post-doctoral research in both Glasgow and Newcastle, Jonathan became part of CELS in the North East. As a Business Solutions Manager he helped biotechnology companies within the North East of England find funding, facilitated collaborations and gave export advice. He currently leads QuantuMDx’s Business Development and Marketing team, helping develop the forward facing aspect of the company and liaising with all partners and prospective business connections. Jonathan has a wealth of experience working in academic, research and commercial environments and managing business relationships.

Dr. Andrea J. Pruijssers is the Research Assistant Professor of Pediatrics at the Vanderbilt Institute for Infection, Immunology and Inflammation. She earned a Masters of Science in Cell and Molecular Biology from Wageningen University in Wageningen, The Netherlands, and a Ph.D. in Entomology from the University of Georgia in Athens, Georgia. She received postdoctoral training in the laboratory of Terence Dermody at Vanderbilt University Medical Center. At Vanderbilt, her research focuses on the development of antiviral therapies for emerging coronavirus (CoV) infections.

Knoxville Beer & Biotech – January 2020

On January 23, join Life Science Tennessee members and friends at Alliance Brewing Company to network with each other, share ideas and hear about the latest life science industry news.

Guest speaker is Michelle French, founder and CEO of ZoeVET and a successful serial entrepreneur for the past 30 years. She has established and exited two privately-owned companies: Stonewall (1989-2008); and Animal Element Inc. (2008-2018), which created and marketed innovative, original veterinary products nationally and internationally.

For her latest venture, Ms. French recognized the significant unmet clinical veterinary needs in the traumatic tissue injury and repair market. She founded ZoeVET based on an exclusive license of the NELL1 tissue regeneration technology developed by NellOne Therapeutics, INC.

RSVP Here!

Life Science Tennessee Beer & Biotech

The Academic Alliance is the leading host of Life Science Tennessee’s Beer & Biotech events. On October 18th in Knoxville, join us as our members and friends socialize and hear from speaker Jonathan Blanchard, Ph.D at Elkmont Exchange Brewery to network with each other, idea share and hear about the latest life science news from interesting speakers. We are excited to see you there!

About our speaker:

Jonathan Blanchard, Ph.D. is an intellectual property attorney with Pitts & Lake P.C. who focuses on the acquisition, defense, and evaluation of IP rights in the areas of chemistry and the life sciences. He will discuss the commercialization of technology and the interplay of patent and trade secret rights to protect ownership of the technology when a product enters the market. Jonathan also will be available for questions and answers after the presentation.”

Register here!

Launch Tennessee now accepting applications for new “SBIR/STTR Matching Fund Grants Program”

(NOTE: This article was originally published on Teknovation.biz)

By Tom Ballard, Chief Alliance Officer, PYA

Tennessee-based entrepreneurs seeking to commercialize technology with funding from two federal initiatives now have another tool in their toolkit, thanks to funding included in the 2017-18 State of Tennessee budget, and the application window is open.

As a result of a more than two-year effort, spearheaded by two statewide organizations – Launch Tennessee and Life Science Tennessee, Governor Bill Haslam recommended and the General Assembly approved $1.5 million for the new “SBIR/STTR Matching Fund Grants Program.” The dollars are non-recurring, meaning they will have to be included in next year’s state budget for the program to be more than a 12-month initiative.

The funding represents an important milestone in efforts to support more technology start-up growth in the Volunteer State. The $1.5 million pot of funds will be used to match federal grants that companies receive to advance their efforts to commercialize technologies important to the federal government. The state’s program has a cap of $150,000 that can be awarded to any one company.

“It allows us to remain competitive and keep really good start-ups here,” Lindsey Cox, Launch Tennessee’s Director of Operations and Government Affairs, said. Several of the states around Tennessee have already implemented similar initiatives, and some start-ups from here have relocated to those states to be eligible for their matching dollars.

Read more here.